Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001654954-25-003161
Filing Date
2025-03-21
Accepted
2025-03-21 17:15:11
Documents
4
Period of Report
2025-03-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A cvm_pre14a.htm PRE 14A 525287
2 cvm_10qimg6.jpg GRAPHIC 29230
3 cvm_10qimg7.jpg GRAPHIC 26322
4 cvm_10qimg8.jpg GRAPHIC 5066
  Complete submission text file 0001654954-25-003161.txt   610286
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: PRE 14A | Act: 34 | File No.: 001-11889 | Film No.: 25761536
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)